New Pharmaceutical Technology

#K-271

New Environmentally Safe and Efficient Technology for the Production of Pharmaceutical Materials

Tech Area / Field

MED-DRG/Drug Discovery/Medicine

Status
3 Approved without Funding

Registration date
18.06.1998

Leading Institute
Research Institute of New Chemical Technologies and Materials, Kazakstan, Almaty

Supporting institutes

The Republican Government Enterprise on the basic of economic control rights “Research Institute for Biological Safety Problems” , Kazakstan, Gvardeiski

Collaborators

Pennsylvania State University / Department of Chemistry, USA, PA, University Park

Project summary

The aim of the project is research, probation and construction works for elaboration a new efficient technology for synthesis of ethyl ether of -bromisovaleric acid and corvalolum and arrangement a small-scale production of them.

The essence of the problem: The offered new technology for synthesis of ethyl ether of -bromisovaleric acid is based on hydroetherification of isobutylene by carbon monoxide and ethanol in the presence of metal complex catalyst. The new technology is environmentally safe and efficient. Production cost is 3-5 times lower than that for the existing industrial method.

The following tasks would be implemented:

– Optimum parameters for EEBIA synthesis would be selected.
– Technology for synthesis of the medicine would be elaborated.
– Pre-clinical and clinical tests for the medicine would be carried out.
– Monographs (medical passports) for the medicine would be prepared.
– Projecting and construction works for arrangement a small-scale production
of the medicine would be carried out.

Back

The International Science and Technology Center (ISTC) is an intergovernmental organization connecting scientists from Kazakhstan, Armenia, Tajikistan, Kyrgyzstan, and Georgia with their peers and research organizations in the EU, Japan, Republic of Korea, Norway and the United States.

ISTC facilitates international science projects and assists the global scientific and business community to source and engage with CIS and Georgian institutes that develop or possess an excellence of scientific know-how.